{
    "id": "828305",
    "text": "In ATCvet, this subgroup is named \"QD05 Drugs for keratoseborrheic disorders\". ==D05A Antipsoriatics for topical use== ::In ATCvet, this subgroup is named \"QD05A Drugs for keratoseborrheic disorders, topical use\". ===D05AA Tars=== ===D05AC Antracen derivatives=== :D05AC01 Dithranol :D05AC51 Dithranol, combinations ===D05AD Psoralens for topical use=== :D05AD01 Trioxysalen :D05AD02 Methoxsalen ===D05AX Other antipsoriatics for topical use=== ::In ATCvet, this subgroup is named \"QD05AX Other drugs for keratoseborrheic disorders for topical use\". :D05AX01 Fumaric acid :D05AX02 Calcipotriol :D05AX03 Calcitriol :D05AX04 Tacalcitol :D05AX05 Tazarotene :D05AX52 Calcipotriol, combinations ==D05B Antipsoriatics for systemic use== ::In ATCvet, this subgroup is named \"QD05B Drugs for keratoseborrheic disorders, systemic use\". ===D05BA Psoralens for systemic use=== :D05BA01 Trioxysalen :D05BA02 Methoxsalen :D05BA03 Bergapten ===D05BB Retinoids for treatment of psoriasis=== :D05BB01 Etretinate :D05BB02 Acitretin ===D05BX Other antipsoriatics for systemic use=== ::In ATCvet, this subgroup is named \"QD05BX Other drugs for keratoseborrheic disorders for systemic use\". :D05BX51 Fumaric acid derivatives, combinations ==References== D05 ",
    "title": "ATC code D05"
}